Genentech, Inc. (JOBS), OSI Pharmaceuticals, Inc. Warn Of Liver Damage From Tarceva, 2 Deaths
WASHINGTON (Reuters) - Genentech Inc and OSI Pharmaceuticals have alerted doctors about cases of liver damage among patients who took the cancer drug Tarceva, U.S. regulators said on Tuesday.